We evaluated a structured pharmaceutical care program for elderly patients (>65 yrs) with congestive heart failure (CHF) based on objective measures of disease control, quality of life, and use of health care facilities in a randomized, controlled, longitudinal, prospective clinical trial.
The 42 patients in group A received education from a pharmacist on the disease and its treatment, and lifestyle changes that could help control symptoms.
Patients also were encouraged to monitor their symptoms and comply with prescribed drug therapy.
If necessary, dosage regimens were simplified in liaison with hospital physicians.
The 41 control patients (group B) received standard care.
The following outcome measures were assessed in all patients at baseline (before the start of the trial) and at 3,6,9, and 12 months : 2-minute walk test, blood pressure, body weight, pulse, forced vital capacity, quality of life [disease-specific (Minnesota Living with Heart Failure questionnaire) and generic (SF-36) ], knowledge of symptoms and drugs, compliance with therapy, and use of health care facilities (hospital admissions, visits to emergency room, emergency calls).
Patients in group A showed improved compliance with drug therapy, which in turn improved their exercise capacity compared with those in group B ; education on management of symptoms, lifestyle changes, and dietary recommendations were also of benefit. (...)
Mots-clés Pascal : Soin pharmaceutique, Insuffisance cardiaque, Personne âgée, Homme, Education santé, Programme éducatif, Chimiothérapie, Traitement, Appareil circulatoire pathologie, Cardiopathie
Mots-clés Pascal anglais : Pharmaceutical care, Heart failure, Elderly, Human, Health education, Educational schedule, Chemotherapy, Treatment, Cardiovascular disease, Heart disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0399109
Code Inist : 002B26E. Création : 22/03/2000.